The Patent Finder

Molecular Transfer, Inc.

13 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
May 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jul 9 to 21, 2027 · next Jul 9
  • 1 fee due Aug 16, 2027
    The maintenance fee for Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells (US 9,259,475) comes due Aug 16, 2027. Unpaid by Feb 16, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,915,230Reagents for transfection of eukaryotic cells
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,765,359Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells
In force
 · High confidence
In forceHigh confidence
US 10,138,497Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells
In force
 · High confidence
In forceHigh confidence
US 10,883,118Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells
In force
 · High confidence
In forceHigh confidence
US 9,259,475Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells
In force
 · High confidence
In forceHigh confidence
US 10,968,240Polycationic Methyl Phospholipids for Improved Delivery of Nucleic Acids to Eukaryotic Cells
In force
 · High confidence
In forceHigh confidence
US 10,155,780Polycationic Methyl Phospholipids for Improved Delivery of Nucleic Acids to Eukaryotic Cells
In force
 · High confidence
In forceHigh confidence
US 12,065,665Agents for Improved Delivery of Nucleic Acids to Eukaryotic Cells
In force
 · Medium confidence
In forceMedium confidence
US 12,043,639Pol Ycationic Methyl Phospholipids for Improved Delivery of Nucleic Acids to Eukaryotic Cells
In force
 · High confidence
In forceHigh confidence
US 12,037,600Transfection Complexes and Methods of Using the Same
In force
 · High confidence
In forceHigh confidence
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
Also on record, not counted in the 13: 5 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 2 abandoned · 2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited